While the SEC isn't talking about the possibility of an investigation into drug developer, Inspire, the company admitted earlier this week that it had received notice that the securities regulator was mulling a lawsuit relating to Inspire's disclosures about a recent drug trial. Inspire first discussed the possibility of an investigation in September '05. Also expected to be targets of an SEC suit are Inspire's Chief Executive Officer Christy Shaffer and Vice President of Operations and Communications Mary Bennett

-- MDT